BIOVENTUS INC. - CLASS A COMMON STOCK

9.9700

23-January-25 16:45:00

15 minutes delayed

Stocks

-0.1200

-1.19%

Today's range

9.9300 - 10.2300

ISIN

N/A

Source

NASDAQ

Bioventus® Management to Present at Canaccord Genuity Growth Conference and Morgan Stanley Virtual Global Healthcare Conference

27 Jul 2021 16:15:00 By Nasdaq GlobeNewswire
Bioventus Appoints Mary Kay Ladone to Board of Directors

14 Jul 2021 16:05:00 By Nasdaq GlobeNewswire
Bioventus Launches OSTEOAMP® SELECT Flowable Nationwide

13 Jul 2021 08:30:00 By Nasdaq GlobeNewswire
Bioventus Invests in Vaporox

24 Jun 2021 16:36:41 By Nasdaq GlobeNewswire
Bioventus to Release Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021

16 Jun 2021 16:05:00 By Nasdaq GlobeNewswire
Bioventus Study Shows Novel Placental Tissue Biologic Candidate Inhibited Inflammatory and Catabolic Responses In Vitro

25 May 2021 09:00:01 By Nasdaq GlobeNewswire
Bioventus Senior Management to Present at Upcoming Investor Conferences

17 May 2021 08:15:00 By Nasdaq GlobeNewswire
Bioventus Inc. Reports First Quarter Results; Updates Full Year 2021 Financial Guidance

12 May 2021 16:05:00 By Nasdaq GlobeNewswire
Bioventus Announces First Commercial Shipment of the Bioness® Integrated Therapy System (BITS) Balance System

27 Apr 2021 08:30:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
5
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.